Product
Grippol
1 clinical trial
8 indications
Indication
InfluenzaIndication
Influenza AIndication
HumanIndication
Influenza BIndication
Influenza A/H3N2Indication
Influenza A H1N1Indication
Acute Respiratory InfectionIndication
Adverse Reaction to ImmunizationClinical trial
Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)Status: Completed, Estimated PCD: 2023-06-15